Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine

10.1371/journal.pone.0076571

Saved in:

Bibliographic Details
Main Authors:	Skibinski D.A.G., Hanson B.J., Lin Y., von Messling V., Jegerlehner A., Tee J.B.S., Chye D.H., Wong S.K.K., Ng A.A.P., Lee H.Y., Au B., Lee B.T.K., Santoso L., Poidinger M., Fairhurst A.-M., Matter A., Bachmann M.F., Saudan P., Connolly J.E.
Other Authors:	PHARMACOLOGY
Format:	Article
Published:	2019
Subjects:	adjuvant aluminum potassium sulfate gamma interferon hemagglutinin immunoglobulin G2a antibody influenza vaccine neutralizing antibody 2009 H1N1 influenza animal experiment animal model animal tissue antibody production antibody titer antigen specificity article bacteriophage cellular immunity covalent bond cross linking cytokine production drug formulation Escherichia coli immunization immunomodulation mouse nonhuman protein domain spleen cell Th1 cell virus like agent virus load Adjuvants, Immunologic Alum Compounds Animals Antibodies, Neutralizing Antibodies, Viral Antibody Specificity Bacteriophages Female Ferrets Hemagglutinin Glycoproteins, Influenza Virus Humans Immunoglobulin G Influenza A Virus, H1N1 Subtype Influenza Vaccines Interferon-gamma Mice Orthomyxoviridae Infections RNA, Bacterial T-Cell Antigen Receptor Specificity T-Lymphocyte Subsets Th1 Cells Vaccines, Virus-Like Particle
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/161461
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-161461
record_format	dspace
spelling	sg-nus-scholar.10635-1614612024-11-15T01:27:57Z Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine Skibinski D.A.G. Hanson B.J. Lin Y. von Messling V. Jegerlehner A. Tee J.B.S. Chye D.H. Wong S.K.K. Ng A.A.P. Lee H.Y. Au B. Lee B.T.K. Santoso L. Poidinger M. Fairhurst A.-M. Matter A. Bachmann M.F. Saudan P. Connolly J.E. PHARMACOLOGY BIOLOGY LIFE SCIENCES INSTITUTE adjuvant aluminum potassium sulfate gamma interferon hemagglutinin immunoglobulin G2a antibody influenza vaccine neutralizing antibody 2009 H1N1 influenza animal experiment animal model animal tissue antibody production antibody titer antigen specificity article bacteriophage cellular immunity covalent bond cross linking cytokine production drug formulation Escherichia coli immunization immunomodulation mouse nonhuman protein domain spleen cell Th1 cell virus like agent virus load Adjuvants, Immunologic Alum Compounds Animals Antibodies, Neutralizing Antibodies, Viral Antibody Specificity Bacteriophages Escherichia coli Female Ferrets Hemagglutinin Glycoproteins, Influenza Virus Humans Immunoglobulin G Influenza A Virus, H1N1 Subtype Influenza Vaccines Interferon-gamma Mice Orthomyxoviridae Infections RNA, Bacterial T-Cell Antigen Receptor Specificity T-Lymphocyte Subsets Th1 Cells Vaccines, Virus-Like Particle 10.1371/journal.pone.0076571 PLoS ONE 8 10 e76571 2019-11-05T02:11:40Z 2019-11-05T02:11:40Z 2013 Article Skibinski D.A.G., Hanson B.J., Lin Y., von Messling V., Jegerlehner A., Tee J.B.S., Chye D.H., Wong S.K.K., Ng A.A.P., Lee H.Y., Au B., Lee B.T.K., Santoso L., Poidinger M., Fairhurst A.-M., Matter A., Bachmann M.F., Saudan P., Connolly J.E. (2013). Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine. PLoS ONE 8 (10) : e76571. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0076571 1932-6203 https://scholarbank.nus.edu.sg/handle/10635/161461 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20191101
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	adjuvant aluminum potassium sulfate gamma interferon hemagglutinin immunoglobulin G2a antibody influenza vaccine neutralizing antibody 2009 H1N1 influenza animal experiment animal model animal tissue antibody production antibody titer antigen specificity article bacteriophage cellular immunity covalent bond cross linking cytokine production drug formulation Escherichia coli immunization immunomodulation mouse nonhuman protein domain spleen cell Th1 cell virus like agent virus load Adjuvants, Immunologic Alum Compounds Animals Antibodies, Neutralizing Antibodies, Viral Antibody Specificity Bacteriophages Escherichia coli Female Ferrets Hemagglutinin Glycoproteins, Influenza Virus Humans Immunoglobulin G Influenza A Virus, H1N1 Subtype Influenza Vaccines Interferon-gamma Mice Orthomyxoviridae Infections RNA, Bacterial T-Cell Antigen Receptor Specificity T-Lymphocyte Subsets Th1 Cells Vaccines, Virus-Like Particle
spellingShingle	adjuvant aluminum potassium sulfate gamma interferon hemagglutinin immunoglobulin G2a antibody influenza vaccine neutralizing antibody 2009 H1N1 influenza animal experiment animal model animal tissue antibody production antibody titer antigen specificity article bacteriophage cellular immunity covalent bond cross linking cytokine production drug formulation Escherichia coli immunization immunomodulation mouse nonhuman protein domain spleen cell Th1 cell virus like agent virus load Adjuvants, Immunologic Alum Compounds Animals Antibodies, Neutralizing Antibodies, Viral Antibody Specificity Bacteriophages Escherichia coli Female Ferrets Hemagglutinin Glycoproteins, Influenza Virus Humans Immunoglobulin G Influenza A Virus, H1N1 Subtype Influenza Vaccines Interferon-gamma Mice Orthomyxoviridae Infections RNA, Bacterial T-Cell Antigen Receptor Specificity T-Lymphocyte Subsets Th1 Cells Vaccines, Virus-Like Particle Skibinski D.A.G. Hanson B.J. Lin Y. von Messling V. Jegerlehner A. Tee J.B.S. Chye D.H. Wong S.K.K. Ng A.A.P. Lee H.Y. Au B. Lee B.T.K. Santoso L. Poidinger M. Fairhurst A.-M. Matter A. Bachmann M.F. Saudan P. Connolly J.E. Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine
description	10.1371/journal.pone.0076571
author2	PHARMACOLOGY
author_facet	PHARMACOLOGY Skibinski D.A.G. Hanson B.J. Lin Y. von Messling V. Jegerlehner A. Tee J.B.S. Chye D.H. Wong S.K.K. Ng A.A.P. Lee H.Y. Au B. Lee B.T.K. Santoso L. Poidinger M. Fairhurst A.-M. Matter A. Bachmann M.F. Saudan P. Connolly J.E.
format	Article
author	Skibinski D.A.G. Hanson B.J. Lin Y. von Messling V. Jegerlehner A. Tee J.B.S. Chye D.H. Wong S.K.K. Ng A.A.P. Lee H.Y. Au B. Lee B.T.K. Santoso L. Poidinger M. Fairhurst A.-M. Matter A. Bachmann M.F. Saudan P. Connolly J.E.
author_sort	Skibinski D.A.G.
title	Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine
title_short	Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine
title_full	Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine
title_fullStr	Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine
title_full_unstemmed	Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine
title_sort	enhanced neutralizing antibody titers and th1 polarization from a novel escherichia coli derived pandemic influenza vaccine
publishDate	2019
url	https://scholarbank.nus.edu.sg/handle/10635/161461
_version_	1821202573796835328

Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine

Similar Items